9 stories to explore.
People report striking changes, subtle changes, and side effects with tesamorelin. Human trials show a narrower, measurable benefit in a specific group.
Copper peptide users report smoother skin, irritation, and no change. Human topical studies offer some leads, but injectable blends are a different question.
KPV has reduced inflammation in several mouse experiments, while people online report mixed results. Here is how to read both kinds of evidence.
Tirzepatide produced substantial weight loss in randomized trials. This guide separates measured health outcomes and real patient experiences from claims of a cure.
CJC-1295 raised growth hormone for days in small human trials. The DAC design matters when reading claims about products sold under the same name.
Ipamorelin stimulated growth hormone in healthy men, but the bowel surgery trial missed its main endpoint. Muscle and fat claims rely mainly on animal studies.
Selank has small human anxiety studies and a larger laboratory record. Learn what the patient reports measured and where safety evidence is missing.
BPC-157 has animal tendon and gut findings but scant human evidence. Compare knee, bladder and bowel reports with the claims about healing.
Part 1: The Molecular Rebellion – Why They Fear the Peptide By Bob Vaughan, Alternative Medicine Expert For years, I’ve been telling anyone who would listen that the future of medicine isn't found in a laboratory's synthetic…